IMMR vs MRT

IMMR presents a classic 'deep value' paradox: it is fundamentally undervalued based on the Graham Number ($19.63) and Intrinsic Value ($13.3), yet it is plagued by a total collapse in technical momentum (0/100). The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while a negative operating margin (-8.03%) suggests that strong revenue growth (59.2%) is not yet translating into operational efficiency. While the dividend is exceptionally safe with a 7.11% payout ratio, the recent massive earnings miss (-382.1% surprise) and consistent price decline suggest a value trap until a catalyst emerges.

MRT exhibits critical financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a negative Price-to-Book ratio of -2.18, indicating negative shareholder equity. While the company shows explosive revenue growth of 143.10% and maintains a strong gross margin of 61.29%, these are offset by severe net losses (-105.62% profit margin) and poor liquidity (Current Ratio 0.97). There is a stark divergence between the 'Strong Buy' analyst consensus and the bearish technical trend (0/100) and deteriorating long-term price performance. The company is currently in a high-risk speculative phase where growth is not yet translating into financial viability.